Rocket Doctor AI Acquires Alea Health, Forging a New Frontier in AI-Driven Mental Healthcare

VANCOUVER, BC – January 08, 2026 – In a strategic move to bolster its position in the digital health landscape, Rocket Doctor AI Inc. (CSE: AIDR) today announced it has completed the acquisition of Alea Health Holdings Ltd., a company specializing in AI-enhanced, therapist-led mental health services. The deal aims to integrate Alea's innovative platform into Rocket Doctor AI's existing ecosystem, significantly expanding its capabilities in mental healthcare and accelerating its mission to serve remote and underserved communities across North America.

The acquisition combines Rocket Doctor AI’s physician-built Global Library of Medicine (GLM) and its sprawling digital health marketplace with Alea Health’s specialized conversational AI, patient-therapist matching technology, and established mental health service platform. This synergy is expected to enhance clinical efficiency, improve the consistency of care, and ultimately broaden access to high-quality mental health support.

“This acquisition represents an important step forward in executing our strategy to build a scalable, physician-led digital health ecosystem,” said Dr. Essam Hamza, Chief Executive Officer of Rocket Doctor AI, in the official announcement. “Alea brings technology and domain expertise that align closely with our Global Library of Medicine and broader platform vision. Together, we are better positioned to support clinicians, improve care consistency, and expand access to high-quality healthcare for patients across North America.”

A Strategic Play in a Consolidating Market

The acquisition arrives at a pivotal moment for the health tech industry, which is experiencing a wave of consolidation. Companies are increasingly using mergers and acquisitions as a primary strategy to integrate advanced AI capabilities, enhance core operations, and achieve scalable growth. Rocket Doctor AI's move reflects this trend, employing a “string-of-pearls” strategy by acquiring specialized technology to fortify its comprehensive platform.

Financially, Rocket Doctor AI has been preparing for growth. The company recently completed an oversubscribed capital raise of C$4.23 million, providing a stronger cash position to fuel strategic initiatives like the Alea Health purchase. While the company has reported persistent net losses, a common trait for growth-stage tech firms, this injection of capital signals investor confidence in its long-term vision. The acquisition itself was structured to be capital-efficient, involving a US $15,000 cash deposit, the issuance of 285,712 common shares valued at CAD $0.70 per share, and the assumption of a US $180,000 SAFE Note obligation payable in monthly installments.

By integrating Alea Health, Rocket Doctor AI not only gains a new suite of technological tools but also deep domain expertise in the rapidly expanding digital mental health sector. This strategic depth is crucial for competing in a market where AI is no longer a novelty but a core driver of efficiency, cost reduction, and improved patient outcomes.

Bridging the Mental Health Gap with AI

At the heart of this deal is the tangible impact on patient access to mental healthcare. Alea Health has distinguished itself with a platform designed to dismantle common barriers to therapy, such as cost, geographic isolation, and the difficulty of finding a suitable provider. Its technology offers a multi-faceted approach to supporting patients and therapists alike.

Alea's core offering includes an advanced client-therapist matching system that uses detailed criteria to foster a strong therapeutic alliance from the outset. More significantly, its platform features a 24/7 conversational AI coach that provides continuous support between sessions. This AI tool can assist with patient intake, conduct follow-ups, summarize key information for the therapist, and monitor a client's symptoms and progress over time. This continuous engagement model aims to improve treatment adherence and effectiveness, particularly for individuals with mild to moderate anxiety and depression.

For a patient in a remote Canadian town or an underserved urban neighborhood in the United States, this technology could be transformative. It replaces long wait times and travel with immediate, secure access to a licensed therapist via video, supplemented by an ever-present AI support system. This aligns directly with Rocket Doctor AI’s foundational mission to leverage technology to reach patients who have historically lacked access to consistent medical care.

“Joining Rocket Doctor AI allows Alea’s technology to scale within a broader clinical and operational framework that is deeply aligned with our original mission,” noted Richard Dallala, Founder and CEO of Alea Health. “We’re excited to see our work integrated into a platform that prioritizes physician leadership, evidence-based care, and meaningful improvements in patient outcomes.”

Empowering Clinicians and Expanding Horizons

While patients are the ultimate beneficiaries, the integrated platform is also designed to empower clinicians. A significant challenge in modern healthcare is physician and therapist burnout, often exacerbated by overwhelming administrative burdens. By automating tasks like patient intake, scheduling, and routine follow-ups, Alea’s technology frees up clinicians to focus on what they do best: providing direct, empathetic care.

The integration with Rocket Doctor AI’s GLM, a clinically validated decision support system, will further augment the capabilities of healthcare providers. The goal is to create a seamless workflow where AI handles administrative logistics and provides data-driven insights, allowing for more meaningful and efficient physician-patient interactions. This restoration of clinical autonomy is a key part of Rocket Doctor AI's value proposition to the more than 300 physicians already using its platform.

Beyond its impact in North America, the acquisition provides Rocket Doctor AI with an unexpected and valuable strategic asset: a foothold in the Middle East. Alea Health has already deployed its mental health coach technology in the United Arab Emirates (UAE) and has a pipeline for expansion across the Gulf Cooperation Council (GCC) region. This provides Rocket Doctor AI its first major entry into a high-growth international market where significant investments in AI and digital healthcare are anticipated, expanding its vision for a global healthcare platform.

However, the road to realizing these synergies involves navigating significant technical and operational challenges. Integrating disparate IT systems, ensuring the secure and seamless migration of sensitive patient data, and harmonizing different organizational cultures are complex tasks. The success of the merger will depend on a meticulous integration strategy that addresses data interoperability, regulatory compliance across different jurisdictions, and robust change management to ensure clinicians and staff fully adopt the new, unified system. The company's ability to navigate these hurdles will be a critical test of its capacity to execute its ambitious growth strategy and truly redefine modern healthcare.